Ascletis Pharma (@ascletisp) 's Twitter Profile
Ascletis Pharma

@ascletisp

ID: 1589465332758052864

calendar_today07-11-2022 03:51:52

124 Tweet

14 Followers

0 Following

Ascletis Pharma (@ascletisp) 's Twitter Profile Photo

Ascletis Announces Positive Topline Results of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Submission of 13-week Phase IIa Study Protocol to FDA ascletis.com/news_detail/19…